![Richard Glickman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Glickman
Chairman at
ENGENE THERAPEUTICS INC.
Net worth: 179 366 $ as of 31/05/2026
Profile
Richard M.
Glickman was the founder of Aurinia Pharmaceuticals, Inc., founded in 1993, where the title held was Chairman & Chief Executive Officer from 2013 to 2019.
Dr. Glickman was the founder of Aspreva Pharmaceuticals Corp., founded in 2001, where the title held was Chairman & Chief Executive Officer from 2001 to 2006.
Dr. Glickman is also the founder of Probtec Corp.,Nventa Biopharmaceuticals Corp.,Stressgen Biotechnologies Corp.,Ontario Molecular Diagnostics,Aurinia Pharmaceuticals, Inc.,Aurinia Pharma Corp...
Dr. Glickman is Chairman at enGene Therapeutics, Inc. since 2024.
Dr. Glickman is Director at MedGenesis Therapeutix, Inc. Dr. Glickman is Director at enGene, Inc. since 2011.
Dr. Glickman is Independent Director at Eupraxia Pharmaceuticals, Inc. since 2021.
Dr. Glickman is Director at Vida Pharmaceuticals Pvt Ltd. Dr. Glickman is Director at Eurpraxia Pharmaceuticals, Inc. Dr. Glickman is Venture Partner at Lumira Capital Investment Management, Inc. Former positions include Chairman at Vigil Health Solutions, Inc. and LifeSciences British Columbia.
Chairman at ESSA Pharma, Inc. from 2010 to 2025.
Lead Independent Director at Correvio Pharma Corp.
Director at Canadian Genetic Disease Network, Vancouver Aquarium, and viDA Therapeutics, Inc. Member at Innovate BC.
Venture Partner at Kearny Venture Partners.
Education includes undergraduate degree from McGill University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 09/03/2026 | 18,860 ( 0.03% ) | 133 717 $ | 31/05/2026 | |
| 16/06/2026 | 24,675 ( 0.04% ) | 45 649 $ | 31/05/2026 |
Richard Glickman active positions
| Companies | Position | Start |
|---|---|---|
| EUPRAXIA PHARMACEUTICALS INC. | Director/Board Member | 09/03/2021 |
| ENGENE THERAPEUTICS INC. | Chairman | 15/05/2024 |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Private Equity Investor | - |
Vida Pharmaceuticals Pvt Ltd. | Director/Board Member | - |
MedGenesis Therapeutix, Inc.
 MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology Provides diagnostic product services | Director/Board Member | - |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Director/Board Member | 23/09/2011 |
Former positions of Richard Glickman
| Companies | Position | End |
|---|---|---|
| ESSA PHARMA INC. | Chairman | 09/10/2025 |
| AURINIA PHARMACEUTICALS INC. | Chief Executive Officer | 29/04/2019 |
Aurinia Pharma Corp.
 Aurinia Pharma Corp. Drugstore ChainsRetail Trade Operates pharmacies | Chief Executive Officer | 01/01/2019 |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Richard Glickman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
52
1st degree connections
24
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 24 |
|---|---|
MedGenesis Therapeutix, Inc.
MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology Provides diagnostic product services | Health Technology |
Nventa Biopharmaceuticals Corp.
 Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes innovative stress protein-based therapeutic vaccines | Health Technology |
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company for commercializing cardiovascular hospital drugs | Health Technology |
Vigil Health Solutions, Inc.
 Vigil Health Solutions, Inc. Internet Software/ServicesTechnology Services Operates as an online platform for senior living, memory care, assisted living, rehab and skilled nursing | Technology Services |
Aspreva Pharmaceuticals Corp.
 Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Health Technology |
Eupraxia Pharmaceuticals, Inc.
 Eupraxia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on the development of delivered, extended-release alternatives to currently approved drugs | Health Technology |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Finance |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stressgen Biotechnologies Corp. /Bioreagents Business/
 Stressgen Biotechnologies Corp. /Bioreagents Business/ BiotechnologyHealth Technology Manufactures and develops biological reagents and related anti-bodies | Health Technology |
Innovate BC
 Innovate BC Miscellaneous Commercial ServicesCommercial Services Develops entrepreneurial talent and supports commercializing technology | Commercial Services |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology Supports and represents the biotechnology and greater life sciences community of Britsh Columbia | Health Technology |
Canadian Genetic Disease Network | |
Kearny Venture Partners
 Kearny Venture Partners Investment ManagersFinance Kearny Venture Partners invests in companies located in the United States. The firm focuses on healthcare and healthcare product sector. It participates in early stage transactions. | Finance |
Vancouver Aquarium
 Vancouver Aquarium Miscellaneous Commercial ServicesCommercial Services Operates aquarium | Commercial Services |
viDA Therapeutics, Inc.
 viDA Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Ontario Molecular Diagnostics | |
Probtec Corp. | |
ESSA Pharma, Inc.
 ESSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
Aurinia Pharmaceuticals, Inc. /Old/
 Aurinia Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products and provides related services | Health Technology |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Aurinia Pharma Corp.
Aurinia Pharma Corp. Drugstore ChainsRetail Trade Operates pharmacies | Retail Trade |
Vida Pharmaceuticals Pvt Ltd. | |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
- Stock Market
- Insiders
- Richard Glickman
Choose MarketScreener 
